AngioDynamics (ANGO) Tops Q3 EPS by 4c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
AngioDynamics Reports Fiscal 2020 Third Quarter Financial Results
April 7, 2020 7:00 AM EDTFiscal 2020 Third Quarter Highlights
Net sales of $69.8 million increased 6.5% compared to the prior-year quarter Gross margin declined 40 basis points to 57.8% year over year GAAP loss per share of $0.15; adjusted earnings per share of $0.01 Launched PATHFINDER I Registry to evaluate performance and clinical outcomes of the AURYON Atherectomy System As a result of the uncertainty created by the COVID-19 pandemic, management is withdrawing its fiscal year 2020 financial guidanceLATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a... More
